Thomas Butt

1.8k total citations · 1 hit paper
40 papers, 965 citations indexed

About

Thomas Butt is a scholar working on Economics and Econometrics, Ophthalmology and Epidemiology. According to data from OpenAlex, Thomas Butt has authored 40 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 9 papers in Ophthalmology and 9 papers in Epidemiology. Recurrent topics in Thomas Butt's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Ophthalmology and Visual Impairment Studies (7 papers) and Retinal Diseases and Treatments (6 papers). Thomas Butt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Ophthalmology and Visual Impairment Studies (7 papers) and Retinal Diseases and Treatments (6 papers). Thomas Butt collaborates with scholars based in United Kingdom, United States and Germany. Thomas Butt's co-authors include Nigel Armstrong, Jos Kleijnen, Steve Ryder, Regina Leadley, Marie Westwood, Shelley de Kock, Gary S. Rubin, Ana Patrícia Marques, Gordon G. Liu and Stephen Morris and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Microbiology.

In The Last Decade

Thomas Butt

36 papers receiving 947 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

2017 351 citations Steve Ryder, Regina Leadley et al. Orphanet Journal of Rare Diseases profile →

Peers

Thomas Butt

OPHTH

EPIDE

RNMI

Yanjun Chen United States

Caroline Murphy United Kingdom

Ginevra Biino Italy

Yoshimune Hiratsuka Japan

Freerk van Dijk Netherlands

Roland Dominic G. Jamora Philippines

Shekhar K. Gadkaree United States

Barbara Topol United States

Maryam Masoumi Iran

Laurie Wagner United States

Yanjun Chen United States

Thomas Butt

181 ×0.5

186 ×1.0

OPHTH

77 ×0.4

EPIDE

117 ×0.8

RNMI

23 ×0.2

Citations per year, relative to Thomas Butt Thomas Butt (= 1×) peers Yanjun Chen

Countries citing papers authored by Thomas Butt

Since Specialization

Citations

This map shows the geographic impact of Thomas Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Butt more than expected).

Fields of papers citing papers by Thomas Butt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Butt. The network helps show where Thomas Butt may publish in the future.

Co-authorship network of co-authors of Thomas Butt

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Butt. A scholar is included among the top collaborators of Thomas Butt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Butt. Thomas Butt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butt, Thomas, et al.. (2025). Balancing Personal Needs and Future Generations’ Well-Being: A Qualitative Pilot Study on Generative Experiences of Emerging Adults with Congenital Heart Disease. Journal of Adult Development.

Specchio, Nicola, Paul Gissen, Emily de los Reyes, et al.. (2024). Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data. PLoS ONE. 19(5). e0302382–e0302382. 2 indexed citations

Shediac, Renée, et al.. (2023). Burden and Treatment of Achondroplasia: A Systematic Literature Review. Advances in Therapy. 40(9). 3639–3680. 14 indexed citations

Butt, Thomas, et al.. (2022). Analysis of greenhouse gas mitigation performance in UK urban areas. Carbon Management. 13(1). 463–481. 4 indexed citations

Savarirayan, Ravi, Wagner Antonio da Rosa Baratela, Thomas Butt, et al.. (2022). Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study. Orphanet Journal of Rare Diseases. 17(1). 224–224. 11 indexed citations

Terheyden, Jan Henrik, Charlotte Behning, Moritz Berger, et al.. (2022). Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report. British Journal of Ophthalmology. 107(8). 1144–1150. 3 indexed citations

Wang, Mengxiao, Nicholas Bloom, Hanqing Zhao, et al.. (2021). Medical disputes and patient satisfaction in China: How does hospital management matter?. The International Journal of Health Planning and Management. 37(3). 1327–1339. 12 indexed citations

Gissen, Paul, Nicola Specchio, Andrew Olaye, et al.. (2021). Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2). Orphanet Journal of Rare Diseases. 16(1). 217–217. 10 indexed citations

Marques, Ana Patrícia, Jacqueline Ramke, John Cairns, et al.. (2020). Estimating the global cost of vision impairment and its major causes: protocol for a systematic review. BMJ Open. 10(9). e036689–e036689. 11 indexed citations

10.

Butt, Thomas. (2018). Measuring the Benefits of Decision Aids for Economic Evaluation. PharmacoEconomics - Open. 3(2). 143–150. 4 indexed citations

11.

Marques, Ana Patrícia, et al.. (2018). The use of informal care by people with vision impairment. PLoS ONE. 13(6). e0198631–e0198631. 19 indexed citations

12.

Ryder, Steve, Regina Leadley, Nigel Armstrong, et al.. (2017). The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet Journal of Rare Diseases. 12(1). 79–79. 351 indexed citations breakdown →

13.

Lee, Aaron, Thomas Butt, Emily Y. Chew, et al.. (2017). Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data. British Journal of Ophthalmology. 102(4). 465–472. 9 indexed citations

14.

Butt, Thomas, Adnan Tufail, & Gary S. Rubin. (2016). Health State Utility Values for Age-Related Macular Degeneration: Review and Advice. Applied Health Economics and Health Policy. 15(1). 23–32. 10 indexed citations

15.

Mulhern, Brendan, Joshua Pink, Donna Rowen, et al.. (2016). Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. Value in Health. 20(4). 687–693. 25 indexed citations

16.

Butt, Thomas & Lorenz von Seidlein. (2015). A Systematic Review of The Impact of Improved Housing Interventions on Health In Low And Middle Income Tropical Settings. Value in Health. 18(7). A564–A564. 1 indexed citations

17.

Borghs, Simon, et al.. (2014). Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy: Real-Life Practice Data Using CPRD. Value in Health. 17(7). A403–A404. 1 indexed citations

18.

Butt, Thomas, et al.. (2014). Investigating the Impact of Perspective on Weighting Qalys: a Discrete Choice Experiment. Value in Health. 17(7). A331–A331. 1 indexed citations

19.

Butt, Thomas, et al.. (2014). Does Price Matter? The Impact of Cost Information On Patient Decision Making. Value in Health. 17(7). A516–A516. 2 indexed citations

20.

Butt, Thomas, et al.. (2013). Patient and Public Preferences for Health States Associated with AMD. Optometry and Vision Science. 90(8). 855–860. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact